Cargando…

N(6)-Methyladenosine Modification of ANLN Enhances Hepatocellular Carcinoma Bone Metastasis

Bones are categorized as the second most prevalent location of extra-hepatic metastasis in Hepatocellular Carcinoma (HCC), which is linked to an extremely poor prognosis due to limited therapeutic options. N(6)-methyladenosine (m(6)A) is a prominent modification involved in HCC, but the exact mechan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Hao, Cheng, Zhang-Jun, Liang, Bo, Wang, Zhen-Guang, Tao, Yuan-Ping, Huang, Sheng-Yu, Ni, Jun-sheng, Li, Hui-Fen, Yang, Le, Yuan, Sheng-Xian, Wu, Jennifer, Kawaguchi, Takumi, Samant, Hrishikesh, Zhou, Wei-Ping, Xiang, Dai-Min, Yang, Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008695/ https://www.ncbi.nlm.nih.gov/pubmed/36923927 http://dx.doi.org/10.7150/ijbs.73570

Ejemplares similares

Overexpression of ANLN in lung adenocarcinoma is associated with metastasis
por: Xu, Jie, et al.
Publicado: (2019)

Knockdown of ANLN inhibits the progression of lung adenocarcinoma via pyroptosis activation
por: Sheng, Li, et al.
Publicado: (2023)

Comprehensive analyses reveal the carcinogenic and immunological roles of ANLN in human cancers
por: Shi, Yanlong, et al.
Publicado: (2022)

Function and evolution of RNA N6-methyladenosine modification
por: Zhu, Zhi-Man, et al.
Publicado: (2020)

Role of N6-methyladenosine RNA modification in gastric cancer
por: Ding, Si-Qi, et al.
Publicado: (2023)

MicroRNA-197-3p acts as a prognostic marker and inhibits cell invasion in hepatocellular carcinoma
por: Ni, Jun-Sheng, et al.
Publicado: (2019)

IL‐17A promotes the invasion–metastasis cascade via the AKT pathway in hepatocellular carcinoma
por: Xu, Qing‐guo, et al.
Publicado: (2018)

Genetic interactions between ANLN and KDR are prognostic for breast cancer survival
por: Dai, Xiaofeng, et al.
Publicado: (2019)

Mechanism of RNA modification N6-methyladenosine in human cancer
por: Zhou, Zijian, et al.
Publicado: (2020)

Alternatively spliced ANLN isoforms synergistically contribute to the progression of head and neck squamous cell carcinoma
por: Guo, Erliang, et al.
Publicado: (2021)

Connecting N6‐methyladenosine modification to ferroptosis resistance in hepatoblastoma
por: Peng, Wan‐Xin, et al.
Publicado: (2022)

N(6)‐methyladenosine (m(6)A) RNA modification in human cancer
por: Huo, Fu‐Chun, et al.
Publicado: (2020)

Pleomorphic adenoma gene 1 mediates the role of karyopherin alpha 2 and has prognostic significance in hepatocellular carcinoma
por: Hu, Zhe-yuan, et al.
Publicado: (2014)

The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer
por: Xu, Xiaoxin, et al.
Publicado: (2023)

Aldolase B inhibits metastasis through Ten–Eleven Translocation 1 and serves as a prognostic biomarker in hepatocellular carcinoma
por: Tao, Qi-fei, et al.
Publicado: (2015)

MicroRNA-212-3p inhibits the Proliferation and Invasion of Human Hepatocellular Carcinoma Cells by Suppressing CTGF expression
por: Chen, Jian-qing, et al.
Publicado: (2019)

N6-Methyladenosine Modification Opens a New Chapter in Circular RNA Biology
por: Wu, Jun, et al.
Publicado: (2021)

N6-methyladenosine modification of PLOD2 causes spermatocyte damage in rats with varicocele
por: Li, Huan, et al.
Publicado: (2023)

Comprehensive bioinformatics analysis reveals the prognostic value, predictive value, and immunological roles of ANLN in human cancers
por: Cui, Zhiwei, et al.
Publicado: (2022)

The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis
por: Zhang, Hui-Min, et al.
Publicado: (2022)

Identification of ANLN as ETV6 partner gene in recurrent t(7;12)(p15;p13): a possible role of deregulated ANLN expression in leukemogenesis
por: Campregher, Paulo Vidal, et al.
Publicado: (2015)

ANLN and TLE2 in Muscle Invasive Bladder Cancer: A Functional and Clinical Evaluation Based on In Silico and In Vitro Data
por: Wu, Sheng, et al.
Publicado: (2019)

The functions of N6-methyladenosine modification in lncRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020)

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022)

ANLN Directly Interacts with RhoA to Promote Doxorubicin Resistance in Breast Cancer Cells
por: Wang, Feng, et al.
Publicado: (2020)

The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial–mesenchymal transition via METTL3-mediated N6-methyladenosine modification of YAP1
por: Ni, Xue-Feng, et al.
Publicado: (2021)

N6-methyladenosine methylation in kidney injury
por: Wang, Qimeng, et al.
Publicado: (2023)

Retraction Note: Downregulation of miR-196-5p induced by hypoxia drives tumorigenesis and metastasis in hepatocellular carcinoma
por: Zheng, Hao, et al.
Publicado: (2023)

Structural Insights into N(6)-methyladenosine (m(6)A) Modification in the Transcriptome
por: Huang, Jinbo, et al.
Publicado: (2018)

CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma
por: Zheng, Hao, et al.
Publicado: (2017)

ANLN Regulated by miR-30a-5p Mediates Malignant Progression of Lung Adenocarcinoma
por: Deng, Feng, et al.
Publicado: (2021)

Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma
por: Zeng, Shuxiong, et al.
Publicado: (2017)

RNA N(6)-Methyladenosine Modifications and the Immune Response
por: Wang, Ya-Nan, et al.
Publicado: (2020)

Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma
por: Zhang, Wenjie, et al.
Publicado: (2022)

Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma
por: Liu, Yong, et al.
Publicado: (2022)

Detection, regulation, and functions of RNA N(6)-methyladenosine modification in plants
por: Tang, Jun, et al.
Publicado: (2023)

METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer
por: Yue, Ben, et al.
Publicado: (2019)

N (6)-methyladenosine modification and METTL3 modulate enterovirus 71 replication
por: Hao, Haojie, et al.
Publicado: (2019)

Detection of N(6)-methyladenosine modification residues (Review)
por: Zhu, Wei, et al.
Publicado: (2019)

Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase
por: Ping, Xiao-Li, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_akeggq3oh45cfk0ten7dco648u